• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lucid Diagnostics Inc (NQ: LUCD )

    0.8439 -0.0161 (-1.87%)
    Streaming Delayed Price Updated: 3:18 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 145,165
    Open 0.8600
    Bid (Size) 0.8304 (1)
    Ask (Size) 0.8500 (35)
    Prev. Close 0.8600
    Today's Range 0.8192 - 0.8600
    52wk Range 0.6301 - 1.721
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
    Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments. 
    Via InvestorPlace
    LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024
    LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -39.29%
    -39.29%
    1 Month
    +5.40%
    +5.40%
    3 Month
    +16.72%
    +16.72%
    6 Month
    -40.99%
    -40.99%
    1 Year
    -36.07%
    -36.07%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    3 Penny Stocks That Could Make a Big Comeback by the End of Q2
    Via InvestorPlace
    Earnings Preview: Lucid Diagnostics
    Via Benzinga
    Earnings Preview For Lucid Diagnostics
    Via Benzinga
    Where Lucid Diagnostics Stands With Analysts
    Via Benzinga
    Preview: Lucid Diagnostics's Earnings
    Via Benzinga
    LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Earnings Scheduled For March 25, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Lucid Diagnostics Earnings Perspective: Return On Capital Employed
    Via Benzinga
    A Preview Of Lucid Diagnostics's Earnings
    Via Benzinga
    PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs
    Via Benzinga
    Earnings Scheduled For November 13, 2023
    Via Benzinga
    Earnings Scheduled For August 14, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why PAVmed Shares Are Falling Today
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    PAVmed and Lucid Diagnostics Provide Strategic Business Update
    From PAVmed Inc.
    Via Business Wire
    PAVmed and Lucid Diagnostics to Provide Strategic Business Update
    From PAVmed Inc.
    Via Business Wire
    PAVmed Partners with Novosound on Ultrasound Imaging Technology
    From PAVmed Inc.
    Via Business Wire
    PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
    From PAVmed Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.